Clinical Trials
42 trialsPeritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)
Rutgers, The State University of New Jersey
EPICH
Fondazione del Piemonte per l'Oncologia
SurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive Surgery
Adichunchanagiri Institute of Medical Sciences, B G Nagara
NUCLEAR
Hospices Civils de Lyon
COCOON
Institut du Cancer de Montpellier - Val d'Aurelle
BIG-RENAPE
Hospices Civils de Lyon
ALBUCHIP
Assistance Publique - Hôpitaux de Paris
PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer
Vilnius University
Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis
University of California, Irvine
PIPADN
Institut de Cancérologie de Lorraine
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
Ohio State University
Preventive Use of PIPAC in Locally Advanced Gastric Cancer.
National Research Oncology and Transplantology Center, Kazakhstan
FAPeCa
Jules Bordet Institute
DWI-PDAC
Laval University
DWI-HighRisk
Laval University
BCBOvaire
Institut du Cancer de Montpellier - Val d'Aurelle
MicroFluO
Assistance Publique - Hôpitaux de Paris
CRS-IP
National Taiwan University Hospital
BOUNCED
Royal Surrey County Hospital NHS Foundation Trust
DCE-MRI
University Hospital, Ghent
OvEpiLyPath
Jules Bordet Institute
Intravital Microscopy (IVM) in Patients With Peritoneal Carcinomatosis (PC)
Mayo Clinic
Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPEC
University of Nebraska
Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study
Cantonal Hospital of St. Gallen
Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis
Zhejiang University
Plasmajet
Maimónides Biomedical Research Institute of Córdoba
ROLLON
Post Graduate Institute of Medical Education and Research, Chandigarh
Role of Magnetic Resonance Enterography for Predicting Peritoneal Cancer Index
Chang Gung Memorial Hospital
Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric Cancer
Fujian Medical University
GASPACCO
St. Petersburg State Pavlov Medical University
FLUOCAR-1
Institut du Cancer de Montpellier - Val d'Aurelle
Intraoperative ICG Fluorescence Imaging for Peritoneal Carcinomatosis Detection
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
DISCO
The Netherlands Cancer Institute
Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies
Albert Einstein College of Medicine
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) : Predictive Marker and Mechanism
Centre Hospitalier Universitaire de Nice
PIPAC-Secure
Institut du Cancer de Montpellier - Val d'Aurelle
CORCAN
Hospices Civils de Lyon
EDMONd
Royal Surrey County Hospital NHS Foundation Trust
Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy
University of Michigan
EIPL
Universitätsmedizin Mannheim
CHIP
Centre Hospitalier Universitaire de Nice
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
Ohio State University Comprehensive Cancer Center